Evidence map›Paper›PMID 42781334›Full record

ArticleJournal of medical biochemistry2026

Serum cystatin C as a biomarker in non-Hodgkin lymphoma and its relationship with paraoxonase 1 activity.

Bosa Mirjanić-Azarić, Smiljana Mijić, Zana Radić-Savić, Siniša Stanković, Dragana Malčić-Zanić, Egeljić Nataša Mihailović, Đorđe Stojisavljević, Bojana Ivetić, Nataša Bogavac-Stanojević

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bosa Mirjanić-AzarićUniversity of Banja Luka, Faculty of Medicine, Department of Medical Biochemistry, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
Smiljana MijićAqualab laboratory, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
Zana Radić-SavićUniversity of Banja Luka, Faculty of Medicine, Department of Medical Biochemistry, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
Siniša StankovićUniversity Clinical Centre of the Republic of Srpska, Department of Nuclear Medicine, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
Dragana Malčić-ZanićUniversity of Banja Luka, Faculty of Medicine, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
Egeljić Nataša MihailovićUniversity Clinical Centre of the Republic of Srpska, Department of Nuclear Medicine, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
Đorđe StojisavljevićUniversity of Banja Luka, Faculty of Medicine, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
Bojana IvetićUniversity Clinical Centre of the Republic of Srpska, Institute of Laboratory Diagnostics, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
Nataša Bogavac-StanojevićUniversity of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This pilot study aimed to assess the potential of cystatin C (Cys C) as a biomarker in non-Hodgkin lymphoma (NHL) and to explore its association with paraoxonase 1 (PON1) activity. Methods: The study included 44 patients with B-cell NHL and 44 healthy subjects. Cys C was measured using the Cobas e 801 analyser (Roche Diagnostics GmbH, Mannheim, Germany), while PON1 and TAS were measured on the ILab 300+ system (Instrumentation Laboratory, Milan, Italy).

Indexed as

cystatin Cnon-Hodgkin lymphomaparaoxonase 1

Identifiers

PMID42781334
PMCPMC13598776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.